300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Iran
Nepal
Madagascar
Isle of Man
Romania
Pakistan
Oman
Puerto Rico
Poland
Andorra
Cameroon
Guernsey
Sudan
Colombia
Armenia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Nicaragua
Mauritius
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Morocco
Cayman Islands
Malawi
Venezuela
Myanmar
Turkey
Uganda
Uruguay
Moldova
Seychelles
Paraguay
Botswana
Japan
Ireland
South Africa
Canada
United Kingdom
France
Georgia
Denmark
Iraq
Ghana
Mali
Malaysia
Latvia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Albania
Asia
Spain
Argentina
Bangladesh
Angola
Europe
Belgium
Barbados
Cyprus
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Qatar
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Howard Goodwin, Partner & Founder at Intrinsic Capital Partners

Howard Goodwin

Partner & Founder @ Intrinsic Capital Partners

Greater Philadelphia Area, United States

Howard Goodwin is a Series A investor at Intrinsic Capital Partners in Greater Philadelphia Area focused on Biotechnology and Health Care. Howard Goodwin is the Partner and Founder of Intrinsic Capital Partners. Howard Goodwin attended the Thomas Jefferson University.

Total investments:
4
Last investment:
Lead investor:
75%

Last updated:

Industries Howard Goodwin invests in

BiotechnologyHealth CareCannabisChemicalBiopharma

Stages Howard Goodwin invests in

Series ASeries DVenture - Series Unknown

Countries Howard Goodwin invests in

United States

Investment Focus

Industry

  • Biotechnology 3 (75%)
  • Health Care 2 (50%)
  • Cannabis 1 (25%)
  • Chemical 1 (25%)
  • Biopharma 1 (25%)
See all 8 industries →

Stage

  • Series A 2 (50%)
  • Series D 1 (25%)
  • Venture - Series Unknown 1 (25%)

Investments

CompanyDescriptionRoundLinks
Nalu Bio Nalu Bio
Nalu Bio is a biotech company developing CBD (and cannabinoids) through chemistry (not plants), for companies who want pure and safe ingredients that are better for the planet. Ranked as the #1 CBD producer on the “google for ingredients.” Like plant-based meats, Nalu Bio will fundamentally disrupt CBD production with chemistry. Nalu Bio uses 700xless land, 70x less water, and 14x less energy to produce its cannabinoids while ensuring best-in-class purity and quality (0% THC, no chemicals, no pesticides) without the high capital investment costs of hemp extraction and biosynthesis. $12M / Series A / Feb 28, 2023
Biopharmaceutical Research Company Biopharmaceutical Research Company
Biopharmaceutical Research Company develops active pharmaceutical ingredients for plant therapeutics. The company focuses on the production of cannabis for researchers across the United States and the USDA-compliant THC testing of hemp. $20M / Series A / Oct 04, 2022
Hound Labs Hound Labs
Hound Labs is a breath technology company that has developed ultra-sensitive technology for non-invasive breath measurement. Utilizing this groundbreaking technology, the HOUND MARIJUANA BREATHALYZER is the world’s first breathalyzer to rapidly, accurately, and inexpensively measure recent marijuana use and alcohol in a person’s breath. The HOUNDBREATHALYZER is intended for law enforcement, employer, and insurance purposes only. Founded in 2014, the Oakland-based company was created by Dr. Mike Lynn, an ER physician, reserve deputy sheriff, and former venture capitalist, his co-founder, Mr. Kuni Oh, a patent attorney with a deep background in engineering and science, and his co-founder, Ms. Jenny Lynn, a business executive with twenty years of experience launching new ventures. Benchmark, Icon Ventures, Intrinsic Capital Partners, Main Street Advisors, NFP Ventures, and individual investors have funded the Company. $20M / Venture - Series Unknown / Sep 03, 2021
Hound Labs Hound Labs
Hound Labs is a breath technology company that has developed ultra-sensitive technology for non-invasive breath measurement. Utilizing this groundbreaking technology, the HOUND MARIJUANA BREATHALYZER is the world’s first breathalyzer to rapidly, accurately, and inexpensively measure recent marijuana use and alcohol in a person’s breath. The HOUNDBREATHALYZER is intended for law enforcement, employer, and insurance purposes only. Founded in 2014, the Oakland-based company was created by Dr. Mike Lynn, an ER physician, reserve deputy sheriff, and former venture capitalist, his co-founder, Mr. Kuni Oh, a patent attorney with a deep background in engineering and science, and his co-founder, Ms. Jenny Lynn, a business executive with twenty years of experience launching new ventures. Benchmark, Icon Ventures, Intrinsic Capital Partners, Main Street Advisors, NFP Ventures, and individual investors have funded the Company. $30M / Series D / Aug 27, 2019

Co-Investors

Intrinsic Capital Partners

About Intrinsic Capital Partners

VC Fund · Philadelphia, United States

Intrinsic Capital Partners is a private equity fund dedicated to investing in promising growth businesses in the emerging legal cannabis industry. Their team has years of investment, pharmaceutical, regulatory, and deal structure experience. Along with our world class network of operating partners with decades of experience building businesses andbrands across healthcare and consumer industries, they are dedicated to creating value for portfolio company owners while generating superior returns for our fund investors.

Intrinsic Capital Partners Contacts

NameEmailPhoneSocials
Cornelius Merlini Managing Partner & Founder
Gerald F Stahlecker Partner & Founder
Howard Goodwin
Howard Goodwin Partner & Founder

Sign up to unlock verified contacts

Unlock Contacts

2 more contacts available

Open Intrinsic Capital Partners full profile

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Iran
Nepal
Madagascar
Isle of Man
Romania
Pakistan
Oman
Puerto Rico
Poland
Andorra
Cameroon
Guernsey
Sudan
Colombia
Armenia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Nicaragua
Mauritius
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Morocco
Cayman Islands
Malawi
Venezuela
Myanmar
Turkey
Uganda
Uruguay
Moldova
Seychelles
Paraguay
Botswana
Japan
Ireland
South Africa
Canada
United Kingdom
France
Georgia
Denmark
Iraq
Ghana
Mali
Malaysia
Latvia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Albania
Asia
Spain
Argentina
Bangladesh
Angola
Europe
Belgium
Barbados
Cyprus
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Qatar
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Howard Goodwin invest in?

Howard Goodwin invests primarily in Biotechnology, Health Care and Cannabis startups, most often at Series A and Series D stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Howard Goodwin last invest?

The most recent investment recorded for Howard Goodwin closed in Feb 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Howard Goodwin Howard Goodwin Find email